OBJECTIVES: This study aimed to assess the long-term outcomes and investigate the factors related to left ventricular (LV) reverse remodelling after aortic valve replacement (AVR) in patients with chronic aortic regurgitation (AR). METHODS: A total of 246 patients who underwent AVR for chronic AR at our institution were included in this retrospective study. Primary end-points included all-cause mortality, cardiac mortality and major adverse cerebral and cardiovascular events. Secondary end-points included cardiac function on echocardiography 1 year after surgery. We explored the predictive factors for reverse remodelling 1 year after surgery. RESULTS: The 10-year survival rate was 86.0%, with no cardiac deaths in 93.8% and no major adverse cerebral and cardiovascular events in 79.9% of patients. Postoperative LV function and symptoms were significantly improved 1 year after surgery, but 34 patients (13.8%) did not recover normal function and structure. A significant negative correlation was found between the incidence of cardiac death and major adverse cerebral and cardiovascular events and reverse remodelling. Multivariate logistic regression identified preoperative LV ejection fraction (P = 0.001, odds ratio = 1.057) and LV end-systolic dimension index (P = 0.038, odds ratio = 0.912) as significant predictive factors of reverse remodelling 1 year after surgery. CONCLUSIONS: Preoperative LV ejection fraction and LV end-systolic dimension index were predictive factors for reverse remodelling after surgery, which was associated with late outcomes. Earlier surgery may thus help to restore normal LV function and achieve better late outcomes after AVR for AR.
OBJECTIVES: This study aimed to assess the long-term outcomes and investigate the factors related to left ventricular (LV) reverse remodelling after aortic valve replacement (AVR) in patients with chronic aortic regurgitation (AR). METHODS: A total of 246 patients who underwent AVR for chronic AR at our institution were included in this retrospective study. Primary end-points included all-cause mortality, cardiac mortality and major adverse cerebral and cardiovascular events. Secondary end-points included cardiac function on echocardiography 1 year after surgery. We explored the predictive factors for reverse remodelling 1 year after surgery. RESULTS: The 10-year survival rate was 86.0%, with no cardiac deaths in 93.8% and no major adverse cerebral and cardiovascular events in 79.9% of patients. Postoperative LV function and symptoms were significantly improved 1 year after surgery, but 34 patients (13.8%) did not recover normal function and structure. A significant negative correlation was found between the incidence of cardiac death and major adverse cerebral and cardiovascular events and reverse remodelling. Multivariate logistic regression identified preoperative LV ejection fraction (P = 0.001, odds ratio = 1.057) and LV end-systolic dimension index (P = 0.038, odds ratio = 0.912) as significant predictive factors of reverse remodelling 1 year after surgery. CONCLUSIONS: Preoperative LV ejection fraction and LV end-systolic dimension index were predictive factors for reverse remodelling after surgery, which was associated with late outcomes. Earlier surgery may thus help to restore normal LV function and achieve better late outcomes after AVR for AR.
Authors: Helmut Baumgartner; Volkmar Falk; Jeroen J Bax; Michele De Bonis; Christian Hamm; Per Johan Holm; Bernard Iung; Patrizio Lancellotti; Emmanuel Lansac; Daniel Rodriguez Muñoz; Raphael Rosenhek; Johan Sjögren; Pilar Tornos Mas; Alec Vahanian; Thomas Walther; Olaf Wendler; Stephan Windecker; Jose Luis Zamorano Journal: Eur Heart J Date: 2017-09-21 Impact factor: 29.983
Authors: Hari P Chaliki; Dania Mohty; Jean-Francois Avierinos; Christopher G Scott; Hartzell V Schaff; A Jamil Tajik; Maurice Enriquez-Sarano Journal: Circulation Date: 2002-11-19 Impact factor: 29.690
Authors: Stefan Hein; Eyal Arnon; Sawa Kostin; Markus Schönburg; Albrecht Elsässer; Victoria Polyakova; Erwin P Bauer; Wolf-Peter Klövekorn; Jutta Schaper Journal: Circulation Date: 2003-02-25 Impact factor: 29.690
Authors: Umesh C Sharma; Paul Barenbrug; Saraswati Pokharel; Willem R M Dassen; Yigal M Pinto; Jos G Maessen Journal: Ann Thorac Surg Date: 2004-07 Impact factor: 4.330
Authors: W L Henry; R O Bonow; J S Borer; J H Ware; K M Kent; D R Redwood; C L McIntosh; A G Morrow; S E Epstein Journal: Circulation Date: 1980-03 Impact factor: 29.690
Authors: Morgan L Brown; Hartzell V Schaff; Rakesh M Suri; Zhuo Li; Li Zhuo; Thoralf M Sundt; Joseph A Dearani; Richard C Daly; Thomas A Orszulak Journal: Ann Thorac Surg Date: 2009-04 Impact factor: 4.330
Authors: Axel Haverich; Thorsten C Wahlers; Michael A Borger; Malakh Shrestha; Alfred A Kocher; Thomas Walther; Matthias Roth; Martin Misfeld; Friedrich W Mohr; Joerg Kempfert; Pascal M Dohmen; Christoph Schmitz; Parwis Rahmanian; Dominik Wiedemann; Francis G Duhay; Günther Laufer Journal: J Thorac Cardiovasc Surg Date: 2014-08-01 Impact factor: 5.209
Authors: George Petrov; Elke Dworatzek; Tabea Marie Schulze; Michael Dandel; Georgios Kararigas; Shokufeh Mahmoodzadeh; Christoph Knosalla; Roland Hetzer; Vera Regitz-Zagrosek Journal: JACC Cardiovasc Imaging Date: 2014-10-08